AJN, American Journal of Nursing:
doi: 10.1097/01.NAJ.0000422249.80459.3b
Drug Watch

New Drug for COPD

Aschenbrenner, Diane S. MS, RN

Collapse Box


* Aclidinium bromide (Tudorza Pressair) is a new powdered, inhaled anticholinergic that has been approved for the treatment of chronic obstructive pulmonary disease. The drug is used daily to prevent or minimize bronchospasms.

* Aclidinium bromide can produce paradoxical bronchospasms and immediate hypersensitivity reactions (especially in those with a history of hypersensitivity to atropine or milk proteins). If either of these occurs, the drug should be discontinued.

© 2012 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics